Mylan to Rebrand Indian API Subsidiary

Generic and specialty pharmaceutical company Mylan (Canonsburg, PA) says it plans to rebrand its Matrix Laboratories (Hyderabad, India) subsidiary as Mylan. Matrix is one of the world's largest suppliers of active pharmaceutical ingredients (API). Mylan acquired a majority stake in Matrix in 2007, and in 2009, Mylan purchased the stake in Matrix that it did not already own from minority shareholders. Mylan says it has integrated the two organizations, along with the generics business of Merck KGaA, to build a global pharmaceutical platform with $5.5 billion...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers